CD5 Stock Chart & Stats
€1.65
--
Market closed
€1.65
--
Day’s Range― - ―
52-Week Range€0.87 - €4.72
Previous CloseN/A
VolumeN/A
Average Volume (3M)112.00
Market Cap
€14.03M
Enterprise Value€30.77
Total Cash (Recent Filing)€2.89M
Total Debt (Recent Filing)€2.81M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Aug 06, 2026EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding16,452,019
10 Day Avg. Volume150
30 Day Avg. Volume112
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)3.62
Price to Sales (P/S)0.42
P/FCF Ratio-10.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.07Price Target Upside85.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.11
Revenue Forecast (FY)€29.12M
Bulls Say, Bears Say
Bulls Say
IntentKey (Audience Modeling) GrowthSustained double‑digit intent‑modeling growth indicates product‑market fit in a high‑value ad‑tech niche. Management guided continued strong YoY growth for each quarter in 2026 and cited an expanding enterprise/government pipeline, which supports recurring revenue and long‑term revenue base expansion.
Platform Integrations And CTV ExposureIntegrations with DSPs, SSPs and FreeWheel materially expand distribution and premium inventory access, enabling scale and better monetization across programmatic channels. Coupled with structural CTV growth (~15% annually), these partnerships increase addressable market and durable commercialization pathways.
Cost Reductions And Improving Loss ProfileSubstantial expense cuts and headcount rationalization have lowered the fixed cost base, improving the trajectory toward operating profitability. The company showed an improved loss profile versus prior years, which enhances runway and reduces the sales/GTM spend required for sustainable margins as IntentKey scales.
Bears Say
Legacy Search Revenue CollapseAn 81% decline in Legacy Search created a large, structural revenue hole and prolonged recovery risk. Legacy services also produced negative net margins and cash burn; until displaced customers or new contracts replace that base, consolidated revenue and cash generation remain impaired.
Severe Margin CompressionA 36‑point gross margin deterioration reflects an adverse revenue mix shift toward lower‑margin Audience Modeling and away from historically high‑margin legacy services. Sustained lower gross margins reduce operating leverage and lengthen the time to positive free cash flow even as revenue grows.
Weak Cash Generation And Reliance On One‑Time ItemsLiquidity is constrained and recent profitability depended on non‑recurring settlement and financing rather than core operations. With TTM free cash flow negative and operating cash flow inconsistent, the company remains exposed if IntentKey conversion timelines or enterprise sales cycles lengthen.
Inuvo News
CD5 FAQ
What was Inuvo Inc’s price range in the past 12 months?
Inuvo Inc lowest stock price was €0.86 and its highest was €4.72 in the past 12 months.
What is Inuvo Inc’s market cap?
Inuvo Inc’s market cap is €14.03M.
When is Inuvo Inc’s upcoming earnings report date?
Inuvo Inc’s upcoming earnings report date is Aug 06, 2026 which is in 9 days.
How were Inuvo Inc’s earnings last quarter?
Inuvo Inc released its earnings results on May 14, 2026. The company reported €0.114 earnings per share for the quarter, beating the consensus estimate of -€0.158 by €0.273.
Is Inuvo Inc overvalued?
According to Wall Street analysts Inuvo Inc’s price is currently Undervalued.
Does Inuvo Inc pay dividends?
Inuvo Inc does not currently pay dividends.
What is Inuvo Inc’s EPS estimate?
Inuvo Inc’s EPS estimate is -0.15.
How many shares outstanding does Inuvo Inc have?
Inuvo Inc has 16,452,019 shares outstanding.
What happened to Inuvo Inc’s price movement after its last earnings report?
Inuvo Inc reported an EPS of €0.114 in its last earnings report, beating expectations of -€0.158. Following the earnings report the stock price went up 5.973%.
Which hedge fund is a major shareholder of Inuvo Inc?
Currently, no hedge funds are holding shares in DE:CD5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Inuvo Inc
Inuvo, Inc., an advertising technology and services company, develops and commercializes large language generative artificial intelligence that discovers and targets digital audiences in the United States. The company offers IntentKey, an artificial intelligence, data analytics, and automation tool that can optimize the purchase and placement of advertising in real time without consumer data, which can serve multiple creative formats including agencies and brands; CTV, video, audio, native, display channels; and platform. The company sells its information technology solutions to agencies, brands, and large consolidators of advertising demand. It markets its products through websites, social media platforms, blogs, public relations, trade shows, and conferences. The company is headquartered in Little Rock, Arkansas.
CD5 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive strategic narrative: the Audience Modeling (IntentKey) business is showing clear product momentum, customer wins, integrations (DSP/SSP/FreeWheel), and double-digit growth, and management is actively cutting costs and refocusing toward higher-margin offerings. However, the company faces material near-term headwinds from an 81% collapse in Legacy Search revenue, significant margin compression (gross margin down to 43% from 79%), constrained liquidity (cash $2.9M) and reliance on one-time settlement and financing. The outlook is promising for long-term growth if IntentKey conversions accelerate, but significant operational and financial risks remain in the near term.View all DE:CD5 earnings summariesCD5 Stock 12 Month Forecast
Average Price Target
€3.07
▲(85.86% Upside)